english

Gastrin-1, rat CAS NO.81123-06-0

Gastrin-1, rat (CAS NO. 81123-06-0) is an 18-amino-acid neuropeptide with the molecular formula C₉₄H₁₂₈N₂₂O₃₁S₂ and molecular weight 2126.32 g/mol. As a species-specific regulator of gastrointestinal function in rats, it is widely used to study gastric acid secretion, gastrin receptor pharmacology, and preclinical drug development.

Send Email

Download

TECHNICAL SPECIFICATIONS

Item	Specification
Product Name	Gastrin-1, rat
CAS NO.	81123-06-0
Appearance	White to off-white lyophilized powder
Molecular Formula	C₉₄H₁₂₈N₂₂O₃₁S₂
Molecular Weight	2126.32 g/mol
Purity (RP-HPLC)	≥ 98.0%
Solubility	Soluble in water (pH 4.0–7.0) or 0.1 M acetic acid; slightly soluble in DMSO (≤5 mg/mL)
Endotoxin	< 1.0 EU/mg
Biological Activity	Binds to cholecystokinin-2 (CCK₂) receptor with high affinity (rat CCK₂ receptor Ki: ~0.1–1 nM), stimulating gastric acid secretion, gastrin release, and growth of gastric mucosa. Species-specific for rat models, critical for studying gastrointestinal physiology and drug development.
Storage Conditions	Lyophilized powder: Store at -20°C in a desiccated, light-protected container; avoid repeated freeze-thaw cycles. After reconstitution, aliquot and store at -80°C (stable for 6 months) or 2–8°C (stable for 1 week).
Stock Location	Stock in USA
MOQ	1g

1.MECHANISM OF ACTION

CCK₂ Receptor Activation: Binds to the cholecystokinin-2 (CCK₂) receptor (rat-specific, Ki: 0.1–1 nM), triggering Gq/11 protein-coupled signaling cascades.

Gastric Acid Secretion: Stimulates enterochromaffin-like (ECL) cells in the stomach to release histamine, which induces gastrin secretion from G cells, ultimately increasing gastric acid production.

Mucosal Growth: Promotes proliferation of gastric mucosal cells via CCK₂ receptor-mediated MAPK/ERK pathway activation, supporting tissue repair and regeneration.

2.PRODUCT INDICATIONS

Gastrointestinal Research: Studying gastric acid regulation, peptic ulcer disease, and gastroesophageal reflux disorder (GERD) in rat models.

Pharmacology Studies: Evaluating CCK₂ receptor antagonists (e.g., proton pump inhibitors, H₂ blockers) and agonists for acid suppression or mucosal protection.

Preclinical Drug Development: Testing the efficacy and safety of anti-ulcer drugs, gastric stimulants, or CCK₂-targeted therapies in rat models.

3.CLINICAL EFFICACY OF PRODUCT

Preclinical Validation:

Increases gastric acid output by 50–70% in pylorus-ligated rat models (ED₅₀: 0.3 nM).

Stimulates gastrin release from isolated rat G cells by 4–6x (concentration: 1 nM).

Promotes gastric mucosal cell proliferation (2–3x increase in BrdU incorporation) in rat explant cultures.

Therapeutic Relevance: CCK₂ receptor antagonists derived from Gastrin-1, rat are in clinical trials for acid-related disorders, with this peptide serving as a key reference standard.

4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.